Page 31 - ebook HCC

28 PROGRAMME AND ABSTRACTS GENEVA, SWITZERLAND EASL HCC SUMMIT 29
FEBRUARY 13 - 16, 2014

CLINICAL PROGRAMME POSTERS

# Title Last name First Name # Title Last name First Name

FINAL ANALYSIS OF EFFICACY AND SAFETY SEVERE 25-HYDROXYVITAMIN D
IN EUROPEAN PATIENTS TREATED WITH
C01 Criotoru Adina E. DEFICIENCY IDENTIFIES HEPATOCELLULAR
SORAFENIB FOR LESS THAN OR GREATER C08 CARCINOMA PATIENTS WITH A POOR Waidmann Oliver
THAN 28 WEEKS IN THE GIDEON STUDY
PROGNOSIS
STUDY OF FACTORS ASSOCIATED WITH Taha Alaa A. C09 PERSONALIZED SORAFENIB THERAPY FOR Maida Marcello
POOR SURVIVAL IN PATIENTS WITH
POSTER BOARDS NONRESECTABLE HEPATOCELLULAR PROSPECTIVE EVALUATION OF THE POSTER BOARDS
HEPATOCELLULAR CARCINOMA
C02
CARCINOMA
CORRELATION BETWEEN HEMOSTATIC
SORAFINEB IN THE MANAGEMENT OF END-
C03 ROLE OF DIETARY SUPPLEMENT AND Mahtab Mamun A. C10 STATUS AND INCIDENCE OF PORTAL Zanetto Alberto
VEIN THROMBOSIS IN PATIENTS WITH
STAGE HCC PATIENTS
LIVER CIRRHOSIS AND HEPATOCELLULAR
CARCINOMA
EVALUATION OF COMBINED
RADIOFREQUENCY ABLATION FOLLOWED LAPAROSCOPIC RADIOFREQUENCY
C04 BY CHEMOEMBOLIZATION VERSUS AbdElMoez Amal T. ABLATION VERSUS HEPATIC RESECTION
CHEMOEMBOLIZATION IN MANAGEMENT OF C11 IN THE TREATMENT OF VERY EARLY Costa Mara
HEPATOCELLULAR CARCINOMA PATIENTS
HEPATOCELLULAR CARCINOMA IN
CIRRHOTIC CARCINOMA: A COHORT STUDY
SORAFENIB FOR ADVANCED
HEPATOCELLULAR CARCINOMA IN SORAFENIB FOR THE TREATMENT
C05 PATIENTS WITH ALCOHOLIC CIRRHOSIS Giovanis Petros OF RECURRENT HEPATOCELLULAR
AND COMORBIDITIES. EFFICACY AND C12 CARCINOMA AFTER LIVER Perricone Giovanni
TOLERABILITY IN REAL-LIFE SETTING TRANSPLANTATION. TWO CASES WITH
FATAL OUTCOME
INFLUENCE OF SARCOPENIA IN SORAFENIB
C06 DISCONTINUATION DURING ADVANCED Gigante Elia PRETREATMENT NEUTROPHIL - TO -
HEPATOCARCINOMA TREATMENT C13 LYMPHOCYTE RATIO IN CIRRHOTIC Shabana Hany R.
PATIENTS WITH HCC
EXPERIENCES WITH LARGE
C07 HEPATOCELLULAR CARCINOMA: JAKARTA Nugroho Adianto THE INDIAN NATIONAL ASSOCIATION FOR
PERSPECTIVE STUDY OF THE LIVER (INASL) CONSENSUS
C14 ON PREVENTION, DIAGNOSIS AND Kumar Ashish
MANAGEMENT OF HEPATOCELLULAR
CARCINOMA IN INDIA